Not sure what is bkl management thinking. First they made a mistake of rushing IF market without enough research. Now they trash the IF price and jeopardise their premium reputation and name in vitamins. If I were the management, I will recall all IF and dispose them quietly. Especially at the current time they are losing share to Swiss. What people will think of the brand of Bkl when they see same standard IF product being offered 50 to 70% cheaper.
I hope bkl share holders get it out quickly, as it seems a management decision issue now
- Forums
- ASX - By Stock
- BAL
- stock
stock, page-1101
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online